Used in the treatment of inflammatory diseases, particularly those driven by interleukin-1 beta (IL-1β) overexpression. It has been investigated for conditions such as rheumatoid arthritis, type 2 diabetes, and certain autoinflammatory disorders. Shows promise in reducing inflammation and disease activity in patients with inadequate response to standard therapies. Also utilized as a reference standard in immunoassay development and biosimilar characterization due to its well-defined target specificity and neutralizing activity against IL-1β.